Multimodal therapy is feasible in elderly anal cancer patients.

CONCLUSION: Patients older than 80 years develop anal cancer, but more often marginal tumors. Even in the oldest age group half of the patients can tolerate standard treatment by a combination of radiation and chemotherapy, and obtain a relative survival of 50% after five years. Fragile patients not considered candidates for chemoradiation may be offered radiation or resection to control local disease.
PMID: 27808666 [PubMed - as supplied by publisher]

Source: Acta Oncologica - November 2, 2016 Category: Cancer & Oncology Authors: Dale JE, Sebjørnsen S, Leh S, Rösler C, Aaserud S, Møller B, Fluge Ø, Erichsen C, Nadipour S, Kørner H, Pfeffer F, Dahl O Tags: Acta Oncol Source Type: research